Opinion|Videos|November 5, 2025

Streamlining Care Models Key to Managing Skin and Soft Tissue Infections

The greatest need in managing skin infections lies in better coordination of care and follow-up rather than in developing new antimicrobial agents.

Although effective antimicrobials are readily available for treating skin and soft tissue infections, the most pressing challenge lies in optimizing care delivery systems. Many patients face barriers such as unstable housing, substance use, or lack of transportation, which hinder proper wound care and adherence to therapy. These social and logistical challenges contribute more to treatment failure than microbial resistance or drug limitations.

Improving the coordination between inpatient and outpatient services could significantly reduce hospital stays and enhance continuity of care. Integrating wound care specialists, social workers, and outpatient clinics into a unified model allows for smoother transitions and better long-term outcomes. Such collaboration not only improves healing but also reduces the burden on emergency and inpatient resources.

While rapid diagnostics and new tools may offer incremental benefits, they are unlikely to solve the systemic challenges underlying poor outcomes. The focus must shift toward efficient algorithms and patient-centered models that address real-world complexities. This evolution represents the next frontier in infection management—streamlining the process rather than simply expanding the pharmacologic arsenal.

Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.